ChinaPeptides(QYAOBIO)

In the past 15 years, we have been committed to providing high quality products and services for many universities and research institutions at home and abroad, and to accelerate and empower frontier scientific research in the field of biomedicine.
According to incomplete statistics, as of December 31, 2022, more than 3200 SCI papers have quoted the services and products of ChinaPeptides. The services and products of ChinaPeptides cited in the literature are mainly peptide synthesis and customization, with a total impact factor of 17,885.896 and an average impact factor of 5.635. In 2022 alone, ChinaPeptides-assisted the publication of 455 SCI literatures, the number of literatures in a single year increased for 10 consecutive years, again reaching a record high.

(Data source: cicada Nest)

According to statistics, in 2022, the total impact factor of the literature on the power of ChinaPeptides is 3631.671, and the average impact factor is as high as 7.98, among which 95 literatures with impact factor scores of more than 10 are high, and the highest impact factor of a single paper is 63.714. "A structural basis for amylin receptor phenotype," published in the journal science on March 25, 2022.
Not arrogant and impetuous, steady forward, the development of ChinaPeptides is inseparable from the support of customers, customers have made scientific research results also let QiangYao people with Rong Yan. In order to be grateful and give back to customers, ChinaPeptides launched the "encourage publication, salute scientific research" activities continue, in line with the rules of the activity of customers can apply to the customer service for ChinaPeptides exclusive paper awards.(Consult customer service for details)
Focusing on peptide synthesis research and development for many years, ChinaPeptides has accumulated a number of patented technologies, with advanced peptide synthesis, purification, lyophilization equipment and perfect process flow. In the future, we will continue to optimize the product line, improve the level of technology research and development, and devote ourselves to providing one-stop biomedical research service solutions for our customers.